Proxy Vote Update: Dr. Reddy’s Laboratories

Below are the resources for and the results of our recent Proxy Vote on behalf of our clients:
 rF Voting Results:
 
1. To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31,             2025, together with the Reports of the Board of Directors and Auditors thereon. – FOR  
2. To declare dividend of Rs. 8/- per equity share for the financial year ended March 31, 2025. – FOR  
3. To re-appoint Mr. G V Prasad (DIN:00057433), as a Director, who retires by rotation, and being eligible offers himself for re-appointment.– AGAINST
4. To approve the re-appointment of Mr. G V Prasad (DIN:00057433) as Whole-Time Director designed as Co-Chairman and Managing Director. – AGAINST
5. Ratification of remuneration payable to Cost Auditors, M/s. Sagar & Associates, Cost Accountant for the financial year ending March 31, 2026.– FOR 
6. To approve appointment of M/s. Makarand M. Joshi & Co., Company Secretaries as Secretarial Auditor of the company. – FOR 


This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.

Facebook
Twitter
LinkedIn
Email

Please Login to Comment.